Nombre del producto:Triphenylmethyl chloride

IUPAC Name:

CAS:76-83-5
Fórmula molecular:C19H15Cl
Pureza:95%+
Número de catálogo:CM000181
Peso molecular:278.78

Unidad de embalaje Stock disponible Precio($) Cantidad
CM000181-500g 1-2 Weeks ŭǯ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :76-83-5
Fórmula molecular:C19H15Cl
Punto de fusión:-
Código de sonrisas:ClC(C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3
Densidad:
Número de catálogo:CM000181
Peso molecular:278.78
Punto de ebullición:
Nº Mdl:MFCD00000813
Almacenamiento:

Column Infos

Zegocractin
CalciMedica announces positive topline data from phase 2b CARPO trial of Auxora™ in Acute Pancreatitis (AP). The trial met primary objective with statistically significant dose response. Calcium release–activated calcium (CRAC) channels are involved in activating T cells, and responsible for regulating calcium-dependent inflammatory pathways or tissue cell injury pathways. AP is a potentially life-threatening inflammatory disease of the pancreas featured by aberrant signaling of calcium.
CalciMedica’s Auxora is a potent and selective intravenous formulated CRAC channel inhibitor containing the active ingredient Zegocractin. It is being developed for the treatment of acute inflammatory and immunologic illnesses, including severe AP, AIPT, AKI, and severe acute respiratory diseases including AHRF, and ARDS.